Singapore is facing an ageing population. This is reflected in the growing number of patients needing to consider starting dialysis in their golden years. In our review, we have found that there is a survival benefit for starting dialysis in our geriatric end-stage renal disease (ESRD) patient with low comorbidity. However, this comes at an expense of reduced quality of life, increased hospitalisation and reduced functional status. The decision to start or withhold dialysis in an elderly patient is a complex one and has to be considered on an individual basis with continuous discussions with the patient and loved ones. Advance Care Planning is a useful tool that can assist in this process.
In addition, a larger proportion of older chronic kidney disease (CKD) patients die before requiring dialysis. One of the earlier studies is by Eriksen et al. They conducted a longitudinal observational study of 3074 Norwegian patients over a 10-year period, with a baseline median eGFR of 75ml/min/1.73m 2 . They demonstrated that increasing age (per 10 year increment) led to a higher mortality (HR 2.28, P=<0.0001), but lower cumulative incidence Review Proceedings of Singapore Healthcare  Volume 21  Number 2  2012 of renal failure (HR 0.75, P=0.0009) 5 . O'Hare et al had similar findings in their cohort of 209,622 US Veterans with CKD stages 3 to 5 followed for a mean of 3.2 years. For patients aged 65 to 84 years, the risk of ESRD exceeded that of death only when the baseline eGFR is less than 15ml/min per 1.73m 2 . Among those aged 85 and over, the risk of death always exceeded the risk of ESRD. They postulated that this may be due to the higher prevalence of comorbidities in the older cohort -Charlson comorbidity index of 4 for those aged above 75 versus 2 or those aged below 45 6 . Cardiovascular cause account for nearly half of all-cause mortality in their cohort of elderly CKD patients 7 . This highlights the importance of managing the cardiovascular risk factors in our geriatric CKD population.
Possible prognostic factors for ESRD and death were explored in a retrospective cohort study conducted by El-Ghoul et al, with 177 CKD patients (initial mean eGFR of 31.8ml/min1.73m 2 ) over the age of 80 years followed-up for a median of 47 months. eGFR <30mL/min/1.73m 2 (HR 13.33, P <0.001), haemoglobin less than 11g/dL (HR 2.05, P=0.02) and proteinuria greater than 1g/24hours (HR 2.88, P <0.001) are associated with increased risk of requiring dialysis. Risk factors for death are progressive CKD (HR 3.59, P=0.001), older age (HR 1.09 for every 1 year, P=0.03), males (HR 2.80, P=0.03) and baseline haemoglobin less than 11g/ dL (HR 2.78, P=0.004). Interestingly, the presence of hypertension and cardiovascular comorbidities did not have a significant effect on risk of ESRD or death 8 .
RENAL REPLAcEMENT THERAPY IN THE ELDERLY
As a Nephrology community, we are now more aware about the lack of guidelines and studies tailored specifically for the elderly. Hence, over the last decade, the interest and knowledge in Geriatric Nephrology has been growing. Nephrologists are now increasingly looking after older patients with ESRD. However, when reviewing the evidence available it is important to be aware of a few limitations. Firstly, the definition of "elderly" varies, from "over 60 years" to "over 80 years" of age. Secondly, survival data coming from different communities and countries cannot be compared without knowing the sociodemographic and clinical characteristics of the patient populations. Finally, randomised controlled trials in certain areas of this field are not possible. Therefore, we rely heavily on retrospective and prospective cohort studies for supporting evidence. Patients in this older age group are more likely to have multiple comorbidities and therefore dialysis decisions in elderly patients must incorporate geriatric principles with emphasis on assessment of function, disabilities, comorbidities and other "geriatric" syndromes.
HAEMODIALYsIs VERsUs PERITONEAL DIALYsIs
To determine the optimal mode of dialysis therapy in the elderly, it is necessary to consider the characteristics, advantages and disadvantages for haemodialysis (HD) and peritoneal dialysis (PD) 9 .
The advantages of HD in the elderly are as follows. Adequacy is easily manipulated and the time spent on the dialysis alone is relatively shorter. It is conducted at a dialysis centre which means it is not dependent on the patients' or caregivers' ability to provide the therapy. The constant contact with the HD centre provides a means of social support for the regular HD patient. The biggest disadvantage is the requirement of a functioning vascular access. The elderly have a higher rate of non-maturing fistulas compared to their younger counterparts 10, 11 . There is also an increased risk of hypotension and the need for transportation of the patient to and from the dialysis centre. In an immobile individual, this travelling may prove challenging.
PD on the other hand does not require vascular access, it has a lower risk of hypotension, maintains residual renal function longer and it is a homebased therapy which negates the need for regular transportation to the HD centre. PD patients also get to enjoy a slightly more relaxed dietary restriction compared to HD. It does, however, require the patient or a dedicated caregiver to perform the dialysis daily. Next, the patient will need to store some of the PD solutions at home. This may be a problem if there are many family members crowding under one roof. In view of the above mentioned, it is not surprising that ESRD patients were more likely to choose PD if they were older (>85 years), had congestive heart failure and severe behavioural disorder 12 .
Currently there are no studies conducted in the elderly to determine which characteristics are important to the patient and their caregiver when deciding on a dialysis modality. Hence, we refer to Proceedings of Singapore Healthcare  Volume 21  Number 2  2012 studies conducted in the general CKD population. Morten et al conducted a survey of 34 Australian CKD stage 4 and 5 patients and caregivers to rank 28 characteristics of dialysis which are important to them. Patients agreed that the most important characteristics were survival, convenience of dialysis at home and presence of dialysis-free days. For caregivers, the most important were convenience of dialysis at home, respite and the ability to travel 13 .
sURVIVAL This survival benefit with dialysis in the elderly is less compared to their younger counterparts. Kurella et al showed a decreasing mean survival after dialysis initiation in the older dialysis population -24.9 months in those aged 65 to 79 years, 15.6 months in those aged 80 to 84 years, 11.6 months for those 85 to 89 years and 8.4 months in those aged 90 years and older 14 . They also demonstrated that the dialysis population had a substantially lower average life expectancy, of 48 to 89 months, than that of the age-matched general population.
As expected, our local data demonstrated that patients aged below 60 years, have a better survival than patients aged 60 and above on both PD and HD. The five-year survival for peritoneal dialysis is 39.6% in those younger than 60 versus 16.2% for those above the age of 60 years (P<0.001) 3 . HD was 70.7% versus 44.0%, respectively (P <0.001) 3 . Unfortunately, we currently do not have local data comparing the survival of our local patients who choose dialysis versus those who choose conservative management. Thus we take our reference from overseas data.
Comparing dialysis versus conservative management, dialysis has a survival benefit. One of the earlier papers on this topic was by Joly et al in 2003 15 . This single centre cohort study included 146 consecutive pre-ESRD French octogenarians who were referred to their centre over a 12-year period. Patients who were not recommended dialysis (25.6%) were more socially isolated (defined as living alone), had lower functional status (mean Karnofsky score 55) and had higher prevalence of diabetes mellitus. The median survival was 28.9 months in the dialysis groups and 8.9 months in the conservative group (P <0.0001). Looking at the dialysis group, patients who were females (HR 2.56), older age (HR 1.13), using central venous catheter for dialysis (HR 2.87) and functionally dependent (Karnofsky <40) (HR 2.34) had a higher one-year mortality. First-year survival was better in patients with a higher body mass index (BMI) (HR 0.83 for every BMI 1-point increase). Thus emphasising the importance of optimising nutrition in our predialysis CKD population. Beyond the first year, the presence of peripheral vascular disease (HR 5.67) or the presence of more than three comorbid conditions (HR 3.73) conferred a higher risk of mortality.
Dialysis may not confer a survival benefit in elderly patients with significant comorbidities. A study in London by Murtagh et al in 2007 also demonstrated survival benefit with dialysis in the elderly (>75 years) 16 . However, in those with ischaemic heart disease or significant comorbidity (score = 2 in a comorbidity scoring system by Davies et al 17 ) there was no survival benefit with dialysis. A study by Shahid et al in 2009 shared similar findings 18 . A French team in 2009 proposed an objective clinical scoring system which assisted in predicting six-month prognosis in the elderly patient starting dialysis for ESRD. Their scoring system included body mass index <18.5 kg/m2 (2 points), diabetes (1), congestive heart failure stages III to IV (2), peripheral vascular disease stages III to IV (2), dysrhythmia (1), active malignancy (1), severe behavioural disorder (2), total dependency for transfers (3) and unplanned dialysis (2) . Mortality rates ranged from 8% in the lowest risk group (0 point) to 70% in the highest risk group (> or =9 points) 19 .
When comparing survival in the elderly started on HD versus PD, there is paucity of data. The NDTS group in London, demonstrated similar 12-month mortality (26.1 versus 26.4 deaths/100 person-years) and hospitalisation rates (1.9 versus 2.0 admissions/person-year) in elderly (>70 years) PD and HD patients 20 . Couchoud also demonstrated no significant difference in survival between the elderly patients (>75 years) initiated on HD versus PD. However, they did show that those started on unplanned HD was associated with a 50% higher risk of mortality compared to planned HD 12 . Hence, it is important to ensure that we adequately prepare our elderly patients for dialysis if they choose to undertake this therapy.
QUALITY OF LIFE
The symptom burden in patients with ESRD is high 21 . Together with their increased comorbidity, elderly ESRD patients have a reduced quality of life and higher prevalence of depression 22 . Locally, only 40.7% of our prevalent dialysis patients over the age of 60 years are capable of normal or near normal activity. This is lower in comparison to our younger dialysis population with 76.5% who have normal or near normal activity 3 .
Dialysis in the elderly is related to higher hospitalisation and complication rate. A recent study by Carson et al showed that the median survival for elderly patients (>75 years) on dialysis was 37.8 months, compared to 13.9 months for those on conservative management (P <0.01). The dialysis cohort had a higher rate of hospitalisation and a lower chance of dying in a hospice or at home with their loved ones (OR 4.15). Thus, although patients on dialysis survived three times longer, 47.5% of their time was spent in hospital or in a dialysis centre. On the other hand, those who were on conservative management only spent 4.3% of their surviving days in hospital 23 . Munshi et al showed that the elderly (>75 years) dialysis population spent 20% of their time in hospital. In addition, they demonstrated that the elderly had a 26% rate of complications whilst on dialysis. These included dialysis related infections, PD related hernias and arteriovenous fistula related problems 24 .
The functional status of our elderly patients will decline after the initiation of dialysis. An United States cohort of nursing home residents with a mean age of 73.4 years were reviewed with regards to their functional status prior and after starting dialysis. At 12 months after the initiation of dialysis, 58% had died and pre-dialysis functional status had been maintained in only 13% 25 . This holds true as well for independent elderly patients (>80 years) initiated on dialysis. After six months, Jassal et al found that more than 30% of these patients had functional loss requiring caregiver support or transfer into a nursing home 26 . These findings were attributed to a few possible factors. Firstly there is a high prevalence of baseline disability and comorbidities in this population. Secondly, the functional decline may be due to hospitalisation during the initiation of dialysis. Thirdly, the psychosocial burden of dialysis and its side-effects -hypotension, cramping or fatigue, may interfere with the rehabilitation process. Finally, the ESRD may be a part of a terminal multi-organ dysfunction for which dialysis alone may not be able to prevent further overall decline.
When comparing dialysis modality, the quality of life in the elderly PD and HD population are similar 20 . The recent BOLDE study also supports this, as there is no significant difference in the Quality of Life assessment scores (SF-12 PCS & MCS) of their elderly (>65 years) PD and HD patients. On the other hand, there is greater depression (HADS) and illness intrusion felt by patients on HD (IIRS) 27 .
TIME LIMITED TRIALs AND WITHDRAWAL OF DIALYsIs
It is worth mentioning that if patients or families remain undecided about dialysis, a time limited trial of dialysis can sometimes be considered. In addition, as the clinical condition of the patient changes over time, it is reasonable to consider withdrawal of dialysis when the burdens of therapy substantially outweigh the benefits 28 . Guidelines have been introduced to assist physicians when trying to make and carry out these difficult decisions 29, 30 . Patients, family and even physicians are rarely aware of the poor prognosis ESRD confers to our elderly patient. For those aged over 65 years, the prognosis with dialysis treatment is similar to that of colorectal cancer and only marginally better than that of lung cancer 33 . In addition, as previously mentioned, our ESRD patients have a high symptom burden. Thus there is a growing recognition that Advance Care Planning and palliative care should not only be considered towards the end of our patient's life. Rather, a simultaneous care model should be implemented early in our CKD care. patient's preferences as the trajectory of decline progresses and end of life issues become more prominent 34 . This is to allow patients to achieve control over their future healthcare, relieve potential burdens on loved ones and strengthen interfamily relationships. Completing written advance directives and documenting a healthcare proxy or surrogate decision-maker, is only a small part of the entire process 35 . The social benefit of patients having had end-of-life discussions with healthcare providers is that they accrued fewer healthcare costs, used less invasive or burdensome procedures and entered hospice care earlier and more frequently 36 .
NON-DIALYsIs MANAGEMENT

ADVANcE cARE PLANNING
The complexities of ACP for patients with CKD are formidable in magnitude. The unique aspect is that there is the availability of replacement therapy for a failing organ and the opportunity to accept or refuse its implementation.
Firstly, patients may not be fully informed or understand their available healthcare options. In a cohort of 584 American CKD stage 4 and 5 patients, they have reported poor self-reported knowledge of their illness trajectory and palliative care options. On starting dialysis, 61% of patients regretted their decision. When asked why dialysis had been chosen over conservative care, 51.9% reported it was their physician's wish and 13.9% chose dialysis because it was their family's wish 37 .
Secondly, it is acknowledged that patients will change their preferences over time. In a cohort of elderly patients (>60 years) with advanced cancer, heart failure or chronic obstructive pulmonary disease, 35% had an inconsistent preference trajectory when asked their willingness to undergo high-burden therapy for a chance to avoid death. These inconsistent trajectories increased to 48% and 49% when asked their willingness to risk physical or cognitive disability, respectively, to avoid death 38 .
Thirdly, healthcare providers may be reluctant to engage in end-of-life discussions for fear of destroying patients' hope 39 . On the contrary, 65.6% of patients are comfortable with having end-oflife discussions with their healthcare provider and 69.7% with their family 37 . In fact, more information earlier in the course of their illness helped patients to imagine possibilities for the future that were consistent with their values and hopes.
Finally, physicians may feel ill prepared to assist in making end-of-life decisions. In a survey conducted on American and Canadian Nephrologist, only 39% of the 360 respondents perceived themselves as well prepared to make end-of-life decisions 40 . Age over 46 years, six or more patients withdrawn from dialysis in the preceding year and awareness of the Renal Physicians Association (RPA)/American Society of Nephrology (ASN) guideline on dialysis decision-making 30 were independently associated with the highest level of self-reported preparedness. Nephrologists who reported being very well prepared were more likely to use timelimited trials of dialysis and stop dialysis of a patient with permanent and severe dementia 40 .
A local survey by Yee et al explored the perception of ACP in our local Nephrology community, where 562 renal healthcare workers responded to the survey. Medical social workers and physicians had higher knowledge scores. Doctors (82.4%) and medical social workers (100%) considered ACP discussions as part of their role. In comparison, only 37.1% of nurses and 38.1% of other allied healthcare professionals thought likewise. Medical social workers were the most confident in conducting ACP discussions. Physicians reported that the main barriers for ACP discussions appeared to be the lack of time, concerns regarding family backlash and the perception that patients were not prepared to discuss ACP 41 .
PALLIATIVE cARE
As previously mentioned, the symptom burden in our dialysis patients is high. Common reported symptoms are fatigue/tiredness 71%, pruritus 55%, constipation 53%, anorexia 49%, pain 47%, sleep disturbance 44%, anxiety 38%, dyspnea 35%, nausea 33%, restless legs 30% and depression 27% 21 . Patients with CK Stage 5 on conservative management, had similar symptoms which had a marked increase in the severity during the last two months of life 42 . Nephrologists must recognise that death and dying is inevitable particularly in our elderly ESRD patients. Thus we should aim to alleviate these symptoms burden throughout their course of CKD. In addition, the psychosocial and spiritual needs of our patients should be met 36 . Once again, position papers from the various Nephrology Associations on the quality care at the end of life are available 43 .
Review
Proceedings of Singapore Healthcare  Volume 21  Number 2  2012 cONcLUsION The decision to start dialysis in the elderly patient is a difficult and personal one. It is guided by one's medical condition and motivated by one's desire to continue or prolong life 44, 45 . In addition, the individual has to accept the inherent risks and burdens associated with dialysis. In the coming years, our department and Singapore General Hospital will embark on this journey to implement ACP into our clinical practice. We hope this will prove to be an additional powerful tool to provide better care for our elderly patients with advance chronic kidney disease.
